Immix Biopharma, Inc. insider trading

IMMXNASDAQ

$9.68-0.55 (-5.38%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+361.0%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25

Unlock quarterly net flow

Key players

JHJason HsuDirector6.8007%of company
YCYekaterina ChudnovskyDirector4.5392%of company
IMIlya M. RachmanCEO and Chairman1.5959%of company
CNCarey NgDirector1.4698%of company
NTNancy T. ChangDirector1.2932%of company
GSGabriel S. MorrisCFO, President1.0378%of company
HCHelen C. AdamsDirector0.253%of company
MMMagda MarquetDirector0.1011%of company
MJMelissa Jane BuchanDirector0.0401%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
IMMX	Ilya M. RachmanCEO and Chairman	Open market purchase$4.98K	+0.1%	$6.67	$4.98K	Dec 10, 2025	Dec 10, 2025
IMMX	Gabriel S. MorrisCFO	Open market purchase$5.07K	+0.2%	$6.58	$5.07K	Dec 10, 2025	Dec 10, 2025

End of history · 2 transactions